Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM
· Real-Time Price · USD
25.75
0.16 (0.63%)
At close: Oct 03, 2025, 3:59 PM
25.73
-0.08%
After-hours: Oct 03, 2025, 07:42 PM EDT
0.63% (1D)
| Bid | 25.66 |
| Market Cap | 2.6B |
| Revenue (ttm) | 60.27M |
| Net Income (ttm) | -398.58M |
| EPS (ttm) | -4.5 |
| PE Ratio (ttm) | -5.72 |
| Forward PE | -5.67 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 25.91 |
| Volume | 2,130,189 |
| Avg. Volume (20D) | 2,621,012 |
| Open | 25.89 |
| Previous Close | 25.59 |
| Day's Range | 25.08 - 26.16 |
| 52-Week Range | 13.53 - 35.25 |
| Beta | 2.25 |
| Ex-Dividend Date | n/a |
About BEAM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BEAM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BEAM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsBeam Therapeutics Inc. is scheduled to release its earnings on
Nov 4, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+0.63%
BEAM stock has given up its prior gain. Beam Thera...
Unlock content with
Pro Subscription
1 month ago
+0.63%
Beam Therapeutics shares are trading higher after the company announced the FDA has granted regenerative medicine advanced therapy designation status for Beam-101.
